日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Caulobacter crescentus Succinylornithine transaminase (astC) CSB-YP860535DQO
CSB-EP860535DQO
CSB-BP860535DQO
CSB-MP860535DQO
CSB-EP860535DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Peptidyl-tRNA hydrolase (pth) CSB-YP860536DQO
CSB-EP860536DQO
CSB-BP860536DQO
CSB-MP860536DQO
CSB-EP860536DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus UPF0324 membrane protein CC_0425 (CC_0425), partial CSB-YP860537DQO
CSB-EP860537DQO
CSB-BP860537DQO
CSB-MP860537DQO
CSB-EP860537DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Glutamate 5-kinase (proB) CSB-YP860538DQO
CSB-EP860538DQO
CSB-BP860538DQO
CSB-MP860538DQO
CSB-EP860538DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Peptide deformylase (def) CSB-YP860539DQO
CSB-EP860539DQO
CSB-BP860539DQO
CSB-MP860539DQO
CSB-EP860539DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus tRNA (guanine-N (1)-)-methyltransferase (trmD) CSB-YP860540DQO
CSB-EP860540DQO
CSB-BP860540DQO
CSB-MP860540DQO
CSB-EP860540DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP860541DQO
CSB-EP860541DQO
CSB-BP860541DQO
CSB-MP860541DQO
CSB-EP860541DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Bifunctional purine biosynthesis protein PurH (purH), partial CSB-YP860542DQO
CSB-EP860542DQO
CSB-BP860542DQO
CSB-MP860542DQO
CSB-EP860542DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Inorganic pyrophosphatase (ppa) CSB-YP860543DQO
CSB-EP860543DQO
CSB-BP860543DQO
CSB-MP860543DQO
CSB-EP860543DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caulobacter crescentus Molybdenum cofactor biosynthesis protein C (moaC) CSB-YP860544DQO
CSB-EP860544DQO
CSB-BP860544DQO
CSB-MP860544DQO
CSB-EP860544DQO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor UPF0225 protein SCO1677 (SCO1677) CSB-YP860545FOB
CSB-EP860545FOB
CSB-BP860545FOB
CSB-MP860545FOB
CSB-EP860545FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP860546DWY
CSB-EP860546DWY
CSB-BP860546DWY
CSB-MP860546DWY
CSB-EP860546DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Cytochrome c oxidase subunit 3 (ctaE), partial CSB-YP860547DWY1
CSB-EP860547DWY1
CSB-BP860547DWY1
CSB-MP860547DWY1
CSB-EP860547DWY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein translocase subunit SecA 1 (secA), partial CSB-YP860548SML
CSB-EP860548SML
CSB-BP860548SML
CSB-MP860548SML
CSB-EP860548SML-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Bis (5'-nucleosyl)-tetraphosphatase, symmetrical (apaH) CSB-YP860549BNS
CSB-EP860549BNS
CSB-BP860549BNS
CSB-MP860549BNS
CSB-EP860549BNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tyrosine-protein kinase CpsD (cpsD) CSB-YP860550SMI
CSB-EP860550SMI
CSB-BP860550SMI
CSB-MP860550SMI
CSB-EP860550SMI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a 60 kDa chaperonin (groL), partial CSB-YP860551LPY
CSB-EP860551LPY
CSB-BP860551LPY
CSB-MP860551LPY
CSB-EP860551LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthine phosphoribosyltransferase (xpt) CSB-YP860552FNQ
CSB-EP860552FNQ
CSB-BP860552FNQ
CSB-MP860552FNQ
CSB-EP860552FNQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Inositol phosphate phosphatase sopB (sopB) CSB-YP860553SKAN
CSB-EP860553SKAN
CSB-BP860553SKAN
CSB-MP860553SKAN
CSB-EP860553SKAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pneumococcal vaccine antigen A (pvaA) CSB-YP860554FMW
CSB-BP860554FMW
CSB-MP860554FMW
CSB-EP860554FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×